Atisnolerbart Biosimilar - Research Grade

Human

BETVIA

>1mg/ml

Human IgG4 - kappa

CHO Cells

Bremzalerbart Biosimilar - Research Grade (ICH5231), Umesolerbart Biosimilar - Research Grade (ICH5282)

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

This catalog entry (ICH5230) is described as a research-grade, unconjugated, non-therapeutic recombinant analog of the originator drug referenced on the card, supplied for research use only and not for human or veterinary use. Like other biosimilar reagents in this range, it is intended to reproduce the antigen-binding character of the originator molecule so that laboratories can run binding, blocking, and control experiments without consuming clinical material. Typical utility for such a reagent includes use as a positive or isotype-matched reference in assay development, as a benchmarking tool alongside novel candidate antibodies, and as a defined input for in-vitro functional and preclinical characterisation. It is offered at low-endotoxin, research-grade purity (routinely under 1 EU/mg, with ultra-low-endotoxin under 0.5 EU/mg options where available) and in bulk milligram-to-gram quantities to support scale-up and screening workflows. IMPORTANT: the originator drug identity and the molecular target on this card could not be independently verified (see flag), so this background is intentionally generic; it should be replaced with target-specific text once the source data is confirmed. The target on this card is listed as "BETVIA", which could not be reconciled with a verified human therapeutic target. The nearest public match is Bet v 1-A, the major pollen allergen of birch (Betula), a small cytoplasmic pathogenesis-related plant protein of the Bet v 1 / PR-10 family that acts as a general ligand-binding (steroid/flavonoid carrier) protein and is a dominant driver of birch-pollen allergy and associated oral allergy syndrome cross-reactivity. That plant allergen is not a credible target for a human IgG4-kappa therapeutic biosimilar, so it is almost certainly a placeholder or mislabel rather than the intended antigen. Because the true target is unconfirmed and no UniProt accession is provided, no specific target biology (expression, signalling, or disease role) is asserted here. Accurate target-biology text must be supplied only after the intended human target is verified.

Major pollen allergen Bet v 1-A

Detects human BETVIA

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks